title: AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.
authors.affiliation: Department of Internal Medicine, Division of Haematology, Medical University, Graz, Austria. gerald.jaeger@meduni-graz.at
authors.forename: Gerald
authors.initials: G
authors.lastname: Jaeger
authors.forename: Werner
authors.initials: W
authors.lastname: Linkesch
authors.forename: Werner
authors.initials: W
authors.lastname: Temmel
authors.forename: Peter
authors.initials: P
authors.lastname: Neumeister
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology; D019008:Drug Resistance, Neoplasm; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D016499:Radioimmunotherapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018951:Antigens, CD20